Alexion brings 2 presentations to BPI 2026 in Boston, its home city. Its sessions focus on upstream process intensification. One uses ultra-high cell density banking to inoculate directly and simplify the seed train, and another applies perfusion and high-throughput scale-down studies to a labile molecule.
| Organization | BPI 2026 Attendance |
|---|---|
Alexion Boston, Massachusetts | 1 Scientist II · 1 Associate Scientist II, BioProcess Development |
AstraZeneca's rare disease business, developing and manufacturing biologics for rare conditions. | Talk Tue Sep 22 9:30am–10:00am |
Instantly find 20 buyers from Alexion
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction